TVS Motor Company’s Chairman Sir Ralf Speth conferred with University of Warwick’s Honorary Doctorate
Singapore, Jan 21, 2023 – (ACN Newswire) – Sir Ralf Speth, Chairman of TVS Motor…
News
Fosun International Expects One-off Negative Impact to be Cleared and Businesses to Bound Back in 2023
HONG KONG, Jan 21, 2023 – (ACN Newswire) – On 20 January 2023, Fosun International…
Lido Advisors Announces Hiring of John McInerney as Director, Senior Wealth Manager
LOS ANGELES–(BUSINESS WIRE)–Lido Advisors, LLC (“Lido”), a leading wealth management firm, announced today that John…
Robbins Geller Rudman & Dowd LLP Files Class Action Against Generac Holdings Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case – GNRC
SAN DIEGO–(BUSINESS WIRE)–Robbins Geller Rudman & Dowd LLP has filed a class action lawsuit seeking…
AnPac Bio-Medical Sciences Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request A Hearing
New York, NY, Jan. 20, 2023 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (the “Company”)…
Cellectis Amends $20 Million Convertible Note Under Collaboration Agreement with its Partner Cytovia Therapeutics
NEW YORK, Jan. 20, 2023 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS –…
KBRA Assigns Preliminary Ratings to GoodLeap Sustainable Home Solutions Trust 2023-1
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to three classes of notes issued by GoodLeap Sustainable…
RiverNorth Opportunities Fund, Inc., RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. and RiverNorth Capital and Income Fund, Inc.* Announce Preferred Dividends
WEST PALM BEACH, Fla.–(BUSINESS WIRE)–RiverNorth Opportunities Fund, Inc., RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. and RiverNorth…
PaxMedica to Present at the Jan 26th Virtual Investor Summit Microcap Event
Presentation on Thursday, January 26th, 2023 at 1:30 PM EST TARRYTOWN, NY, Jan. 20, 2023…
StorX Network (SRX) is Now Listed on Coinstore.com
Dubai, United Arab Emirates–(Newsfile Corp. – January 20, 2023) – StorX Network ($SRX) is listed…
Kerecis Announces New Fish-Skin Burn Products
ARLINGTON, Va. & REYKJAVIK, Iceland–(BUSINESS WIRE)–#burnwounds–Kerecis, the company pioneering the use of fish skin and…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Y-mAbs Therapeutics, Inc. (YMAB) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ESS Tech, Inc. (GWH)
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming March 13,…
QuintEvents Appoints Nick Cardinale as Chief Operating Officer
Cardinale steps into the role with Quint following years of experience in the sports business…
Hyatt Strengthens Position as Leader in Luxury, Lifestyle and Leisure in 2023 and Beyond with Record Global Pipeline
Hyatt’s transformative growth continues with planned acquisition of Dream Hotel Group, global expansion of Caption…
Windtree Therapeutics to Raise $1.0 Million From the Exercise of Previously Issued Warrants
WARRINGTON, Pa., Jan. 20, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NASDAQ: WINT) (“Windtree” or the…
Disc Medicine Announces Exclusive Licensing Agreement with Mabwell Therapeutics for Novel Anti-TMPRSS6 Monoclonal Antibodies to Modulate Iron Homeostasis
Disc will obtain exclusive rights to MWTX-003 and other novel anti-TMPRSS6 antibodies in the United…
Psyence Group Completes Export of Pharma Grade Psilocybin Extract to UK
TORONTO, Jan. 20, 2023 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF)…
Mindset Pharma Receives Allowance for U.S. Patent Application Covering Composition of Matter for Its Lead Psychedelic Therapeutic Candidate, MSP-1014, And Additional Family 1 Tryptamine Prodrug Candidates
TORONTO, Jan. 20, 2023 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…
Flaggemelding relatert til PCIB
Myrlid AS har i dag, 20. januar 2023, solgt 450 000 aksjer i PCI Biotech…